Glycochenodeoxycholate Promotes Liver Fibrosis in Mice with Hepatocellular Cholestasis

Autor: Ulrich Beuers, Veronika Kanitz, Ralf Wimmer, Coen C. Paulusma, Andreas E. Kremer, Simon Hohenester, David Horst, Gerald Denk, Helen Kuehn, Ronald P.J. Oude Elferink
Přispěvatelé: Graduate School, Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology Endocrinology Metabolism, Gastroenterology and Hepatology
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
Liver Cirrhosis
Liver fibrosis
Cell
Inbred C57BL
Mice
0302 clinical medicine
Liver Cirrhosis/complications
Fibrosis
Medizinische Fakultät
Phospholipid Transfer Proteins
lcsh:QH301-705.5
Cells
Cultured

liver fibrosis
hepatic stellate cell
Adenosine Triphosphatases
Cultured
Chemistry
General Medicine
3. Good health
Hepatocytes/pathology
medicine.anatomical_structure
Liver
030211 gastroenterology & hepatology
Collagen
Myofibroblast
Hydrophobic and Hydrophilic Interactions
Liver/metabolism
medicine.medical_specialty
Mitogen-Activated Protein Kinase Kinases/metabolism
MAP Kinase Signaling System
EGFR
Cells
Cholestasis/complications
Article
03 medical and health sciences
Cholestasis
Glycochenodeoxycholic Acid
Internal medicine
Collagen/metabolism
medicine
Hepatic Stellate Cells
Animals
Humans
bile salts
ddc:610
Cell Proliferation
Mitogen-Activated Protein Kinase Kinases
Messenger RNA
Adenosine Triphosphatases/metabolism
Feeding Behavior
medicine.disease
In vitro
Hepatic Stellate Cells/metabolism
Mice
Inbred C57BL

030104 developmental biology
Endocrinology
lcsh:Biology (General)
Gene Expression Regulation
Chronic Disease
Hepatic stellate cell
Hepatocytes
Phospholipid Transfer Proteins/metabolism
cholestasis
Zdroj: Cells, 9(2):281. MDPI Multidisciplinary Digital Publishing Institute
Cells
Volume 9
Issue 2
Cells, Vol 9, Iss 2, p 281 (2020)
ISSN: 2073-4409
Popis: Hydrophobic bile salts are considered to promote liver fibrosis in cholestasis. However, evidence for this widely accepted hypothesis remains scarce. In established animal models of cholestasis, e.g., by Mdr2 knockout, cholestasis and fibrosis are both secondary to biliary damage. Therefore, to test the specific contribution of accumulating bile salts to liver fibrosis in cholestatic disease, we applied the unique model of inducible hepatocellular cholestasis in cholate-fed Atp8b1G308V/G308V mice. Glycochenodeoxycholate (GCDCA) was supplemented to humanize the murine bile salt pool, as confirmed by HPLC. Biomarkers of cholestasis and liver fibrosis were quantified. Hepatic stellate cells (HSC) isolated from wild-type mice were stimulated with bile salts. Proliferation, cell accumulation, and collagen deposition of HSC were determined. In cholestatic Atp8b1G308V/G308V mice, increased hepatic expression of &alpha
SMA and collagen1a mRNA and excess hepatic collagen deposition indicated development of liver fibrosis only upon GCDCA supplementation. In vitro, numbers of myofibroblasts and deposition of collagen were increased after incubation with hydrophobic but not hydrophilic bile salts, and associated with EGFR and MEK1/2 activation. We concluded that chronic hepatocellular cholestasis alone, independently of biliary damage, induces liver fibrosis in mice in presence of the human bile salt GCDCA. Bile salts may have direct pro-fibrotic effects on HSC, putatively involving EGFR and MEK1/2 signaling.
Databáze: OpenAIRE